A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma
Linnaeus Therapeutics, Inc.
Linnaeus Therapeutics, Inc.
TuHURA Biosciences, Inc.
Replimune, Inc.
The Netherlands Cancer Institute
Cancer Research UK
Cancer Research UK
Cancer Research UK
Cancer Research UK
Second Affiliated Hospital of Guangzhou Medical University